首页> 外国专利> CHIRAL DIARYL MACROCYCLE AND USE THEREOF IN THE TREATMENT OF CANCER

CHIRAL DIARYL MACROCYCLE AND USE THEREOF IN THE TREATMENT OF CANCER

机译：手性二尖瓣大环化合物及其在癌症治疗中的应用

页面导航

摘要
著录项
相似文献

摘要

This disclosure relates to the use of certain diaryl macrocycle compounds, specifically (7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14-tetrahydro-1,15-ethenopyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one in the treatment of disease in mammals. This disclosure also relates to compositions including such compounds, and to methods of using such compositions in the treatment of diseases in mammals, especially in humans.

机译：本公开涉及某些二芳基大环化合物的用途，特别是（7 I，13 R ）-11-氟-7,13-二甲基-6,7,13 ，14-tetrahydro-1,15-ethenopyrazolo [4,3- f ] [1,4,8,10] benzoxatriazazacyclotridecin-4（5 H ）-哺乳动物疾病的治疗。本公开内容还涉及包含此类化合物的组合物，以及使用此类组合物治疗哺乳动物，尤其是人类疾病的方法。 ~~展开▼~~

著录项

公开/公告号EP3733187A1

专利类型

公开/公告日2020-11-04

原文格式PDF

申请/专利权人 TURNING POINT THERAPEUTICS INC.;
展开▼

申请/专利号EP20200181616

发明设计人 CUI JINGRONG JEAN;LI YISHAN;ROGERS EVAN W.;ZHAI DAYONG;DENG WEI;HUANG ZHONGDONG;
展开▼

申请日2016-07-20

分类号A61K31/519;A61K31/52;C07D491/16;C07D491/12;C07D491/18;C07D498/18;A61P35;

国家 EP

入库时间 2022-08-21 11:39:04

相似文献

专利

外文文献

中文文献

1. 一种基于大环化合物光敏染料与二氧化钛的杂化材料及其制备方法和在光催化中的应用 [P] . 中国专利： CN107899618B . 2020.09.15

2. 一种基于大环化合物光敏染料与二氧化钛的杂化材料及其制备方法和在光催化中的应用 [P] . 中国专利： CN107899618A . 2018-04-13

3. Chiral diaryl macrocycle and its use in the treatment of cancer [P] . DK3325488T3 . 2020-09-14

机译：手性二芳基大环化合物及其在癌症治疗中的应用

4. Chiral diaryl macrocycles as modulators of protein kinases [P] . US11008337B2 . 2021-05-18

机译：手性亚芳基宏γ作为蛋白激酶的调节剂

5. Chiral diaryl macrocycles as modulators of protein kinases [P] . AU2020217336A1 . 2020-08-27

机译：手性二芳基大环化合物作为蛋白激酶的调节剂

1. Synthesis of Novel C2-Symmetric Chiral Polyamide Macrocycles Containing Pyridyl Side-arm [J] . 中国化学快报（英文版） . 2002,第011期

2. Paradigm shift in cancer treatment: Cancer treatment as a metabolic disease-fusion of Eastern and Western medicine [J] . Reo Hamaguchi, Hiromi Wada 中医科学杂志（英文） . 2017,第004期

3. Paradigm shift in cancer treatment: Cancer treatment as a metabolic disease-fusion of Eastern and Western medicine [J] . Reo Hamaguchi, Hiromi Wada 中医科学杂志(英文) . 2017,第004期

4. Chirality Exchange from sp~3 Central Chirality to Axial Chirality: Benzannulation of Optically Active Diaryl-2,2-dichlorocyclopropylmethanols to Axially Chiral α-Arylnaphthalenes [J] . Yoshinori NIshii, Kazunori Wakasugi, Keisuke Koga, Journal of the American Chemical Society . 2004,第17期

5. A mild access to chiral syn 1,2-diaryl glycols by stereoselective ring opening of ortho substituted trans 2,3-diaryl-oxiranes using Amberlyst 15 in H2O/THF system [J] . Lupattelli Paolo, Chiummiento Lucia, Funicello Maria, Tetrahedron . 2015,第34期

6. Self-assembly of chiral coordination polymers and macrocycles: A metal template effect on the polymer-macrocycle equilibrium [J] . Burchell TJ, Puddephatt RJ Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics . 2005,第10期

7. LANGMUIR-SCHAEFER FILMS OF A NEW CALIX4PYRROLE-BASED MACROCYCLE EXHIBITING INDUCED CHIRALITY UPON DIFFERENTIATED BINDING WITH CHIRAL ALCOHOL VAPOURS [C] . S. SORTINO, S. PETRALIA, B. PIGNATARO, Sensors and Microsystems . 2004

8. Utilization of the beta-Lactum Core Towards the Preparation of Chiral Ring-Fused Lactams and Preparation and Application of Synthetic Peptide Libraries Toward the Discovery and Understanding of Membrane-Permeable Macrocycles. [D] . Hewitt, William Merton. 2014

9. Chiral metal–macrocycle frameworks: supramolecular chirality induction and helicity inversion of the helical macrocyclic structures [O] . Ryou Kubota, Shohei Tashiro, Mitsuhiko Shionoya 2016

10. Chirality Exchange from sp3 Central Chirality to Axial Chirality: Benzannulation of Optically Active Diaryl-2, 2-dichlorocyclopropylmethanols to Axially Chiral a-Arylnaphthalenes [O] . -1

1. Cancerous multi-drug resistance is reduced by Leptomycin B treatment in CCRF-CEM/Taxol cellsCancerous multi-drug resistance is reduced by Leptomycin B treatment in CCRF-CEM/Taxol cells [J] . Jin-Wu Zhu ,Yong-Xiang Zhang ,Yong-Biao Guan . 健康（英文） . 2012,第10期

2. Spatiotemporal switching signals for cancer stem cell activation in pediatric origins of adulthood cancer:Towards a watch-and-wait lifetime strategy for cancer treatment [J] . Shengwen Calvin Li ,Mustafa H Kabeer . 世界干细胞杂志：英文版（电子版） . 2018,第2期

3. 重要的手性反应、手性试剂、手性技术的现状分析及应用研究——手性环氧卤丙烷的动力学拆分及在手性药物合成中的应用 [C] . 王立新 . 2008(第四届)全国医药中间体研发进展及市场前景研讨会 . 2008

4. 二尖瓣成形术在成人二尖瓣反流治疗中的应用 [A] . 似继承 . 2015